Richard C. Rosenzweig - Jul 11, 2025 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Signature
/s/ Jessica Causey, Attorney-In-Fact for Richard C. Rosenzweig
Stock symbol
XRAY
Transactions as of
Jul 11, 2025
Transactions value $
$960
Form type
4
Date filed
7/15/2025, 04:53 PM
Previous filing
Apr 15, 2025
Next filing
Oct 15, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ROSENZWEIG RICHARD C EVP, Corp Dev, GC & Secretary C/O DENTSPLY SIRONA INC, 13320-B BALLANTYNE CORPORATE PLACE, CHARLOTTE /s/ Jessica Causey, Attorney-In-Fact for Richard C. Rosenzweig 2025-07-15 0001206725

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XRAY Common Stock Award $0 +595 +0.71% $0.00 84.4K Jul 11, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP Award $960 +59.3 +0.99% $16.20 6.06K Jul 11, 2025 Common Stock 59.3 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2 Includes 370 shares acquired between January 1st - June 30, 2025 under the Dentsply Sirona Employee Stock Purchase Plan.
F3 Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.
F4 Comprised of phantom stock acquired as a result of accrued dividends.

Remarks:

Exhibit 24 - Power of Attorney